Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases

By Bedu Elodie   Wahli Walter   Desvergne Béatrice  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 861-873

Informa Healthcare

Access to resources Recommend Favorite

Potential therapeutic role of peroxisome proliferator activated receptor-γ agonists in psoriasis

By Malhotra Samir   Bansal Dipika   Shafiq Nusrat   Pandhi Promila   Kumar Bhushan  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1455-1461

Informa Healthcare

Access to resources Recommend Favorite

Macrophage peroxisome proliferator activated receptor γ as a therapeutic target to combat Type 2 diabetes

By Pascual Gabriel   Ricote Mercedes   Hevener Andrea L  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1503-1520

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-γ Agonists for Management and Prevention of Vascular Disease in Patients with and without Diabetes Mellitus

By Ríos-Vázquez Ramón   Marzoa-Rivas Raquel   Gil-Ortega Ignacio   Juan Carlos Kaski  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 4, 2006-01 ,pp. : 231-242

Adis International

Access to resources Recommend Favorite

The Role of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Alzheimer's Disease: Therapeutic Implications

By Jiang Qingguang  

CNS Drugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 1-14

Adis International

Access to resources Recommend Favorite